Imodium Duo (Dimeticone, Loperamide Hydrochloride)

Loperamide Hydrochloride acts on μ‑opioid receptors located in the intestinal wall. By binding to these receptors, it slows intestinal motility, decreases the propulsion of contents, and reduces fluid secretion, which together help to firm up stools and lessen the urgency of bowel movements.

The appropriate dose of Imodium Duo is determined by a healthcare professional based on the individual's age, weight, and severity of symptoms. Prescribers typically tailor the regimen to each patient, and patients should follow the specific instructions provided by their clinician or pharmacist.

Safety data for Imodium Duo in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this medication.

To order Imodium Duo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any necessary import documentation.

Imodium Duo combines loperamide with dimeticone, offering both reduced intestinal motility and gas‑bubble dispersion. Compared with loperamide‑only products, the addition of dimeticone can provide extra relief from bloating and gas, making it a broader‑spectrum option for patients who experience both diarrhea and gas‑related discomfort.

Imodium Duo should be stored at ambient temperature below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Imodium Duo is supplied as a chewable tablet. The tablet should be chewed thoroughly before swallowing, allowing the active ingredients to be released in the mouth and then absorbed through the gastrointestinal tract for optimal effect.

Serious risks include severe constipation that can lead to intestinal obstruction, ileus, allergic reactions such as rash or swelling, and rare cardiac arrhythmias, especially when loperamide levels become elevated. Patients should seek immediate medical attention if they experience any of these severe symptoms.

Imodium Duo should be avoided by individuals with known hypersensitivity to loperamide or dimeticone, children under 2 years of age, patients with infectious diarrhea accompanied by fever or blood in the stool, and those with severe hepatic impairment unless directed by a physician.